Results 141 to 150 of about 18,746 (183)

Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review. [PDF]

Medicine (Baltimore)
Xing B, Yang J, Hua H, Jiang R.
europepmc   +1 more source

Impact of dose and compliance of antidementia medications on long-term outcomes in Alzheimer's disease: a nationwide real-world study. [PDF]

Alzheimers Res Ther
Kim T, Hong YJ, Kim M, Bae Y, Lee SB, Kim SH, Lee MA, Ko E, Park JW, Yang DW.   +9 more
europepmc   +1 more source

Clinicians' Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer's Disease Treatment in Spain: The VIITAL 2S Study. [PDF]

Patient Prefer Adherence
Piñol-Ripoll G, Salas Carrillo M, VIITAL 2S study group.   +2 more
europepmc   +1 more source

Erratum. [PDF]

Arq Neuropsiquiatr
europepmc   +1 more source

Assessing Cardiovascular Dysfunction Using Cardiac Strain After Diphenhydramine Overdose. [PDF]

Cureus
Kidess GG, Roberts N, Harvey L, Bowe N, Cuddeback E, Brackney AR, Yakey B, Dowers C, Clark CR.   +8 more
europepmc   +1 more source

Alzheimer's Disease: The Current and Emerging Treatment Approaches. [PDF]

Behav Neurol
Pang R, Jia Q, Ma C, Li T, Bi W, Wang H, Liu R, Chen P, Lee ES, Jiang HB.   +9 more
europepmc   +1 more source

Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs. [PDF]

Antioxidants (Basel)
Dias I, Emmanuel M, Vogt P, Guerreiro-Oliveira C, Melo-Marques I, Cardoso SM, Guedes RC, Chaves S, Santos MA.   +8 more
europepmc   +1 more source

Comparative Effectiveness of Rivastigmine and Donepezil in Patients With Alzheimer's Disease: A Retrospective Cohort Study. [PDF]

Cureus
Abbas Raja A, Amjad A, Choudhary A, Atta A, Atta M, Hussain S, Khan M.   +6 more
europepmc   +1 more source